NEW Season 1 Oct 29, 2026 · 17 min
Trump Administration Allows Compounding Pharmacies to Make Popular Peptides
Contains AI NPR News reports on a major policy shift from the Department of Health and Human Services allowing small compounding pharmacies to manufacture six popular, unapproved peptide compounds. This episode explores the background of FDA regulations, compounding pharmacy practices, soaring consumer demand for metabolic and anti-aging therapies, and the ongoing debate among public health analysts regarding patient access, manufacturing capacity, and safety standards. #Peptides #CompoundingPharmacies #HealthPolicy #NPRNews This episode includes AI-generated content.
Listener moments on the timeline Moments: 0
0:00 16:49